RE: ScottPalmer25027 May 2019 18:24
Hmm.
Having listened to the GL interview, it still seems to me that the risk of additional trials is too high.
Gl did not put probabilities on the options, other than hoping labelling and monitoring will be enough.
But if it is not, funding is not going to be pretty.
I've taken my hit and walked away, but appreciate that some will be in too deep and just hoping for the best, I can understand how that might feel.
Hope it works out, but i am not confident enough to re invest at this level.